Pasithea Therapeutics Corp.
KTTA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3,453 | $9,339 | $16,208 | $40,725 |
| - Cash | $6,923 | $16,331 | $33,147 | $52,967 |
| + Debt | $0 | $82 | $927 | $0 |
| Enterprise Value | -$3,470 | -$6,911 | -$16,012 | -$12,242 |
| Revenue | $0 | $0 | $0 | $15 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | -$5 | -$2 |
| % Margin | – | – | – | -14.7% |
| EBITDA | -$13,601 | -$15,331 | -$11,723 | -$4,506 |
| % Margin | – | – | – | -29,916.6% |
| Net Income | -$13,905 | -$15,962 | -$13,936 | -$2,174 |
| % Margin | – | – | – | -14,430.5% |
| EPS Diluted | -12.69 | -13.01 | -10.34 | -1.89 |
| % Growth | 2.5% | -25.8% | -447.1% | – |
| Operating Cash Flow | -$13,923 | -$13,425 | -$13,691 | -$3,174 |
| Capital Expenditures | -$0 | -$34 | -$107 | -$22 |
| Free Cash Flow | -$13,923 | -$13,460 | -$13,798 | -$3,196 |